Literature DB >> 28341364

Decreased access to bariatric care: an analysis of referral practices to bariatric specialists.

John A Primomo1, Tanyaradzwa Kajese2, Garth Davis3, Robert Davis3, Shinil Shah2, Maddie Orsak3, Christina Morrison4.   

Abstract

BACKGROUND: Substantial evidence reveals tolerability and co-morbid disease resolution after bariatric surgery; however, few physicians refer morbidly obese patients for bariatric consultation.
OBJECTIVE: To evaluate morbidly obese patient access to bariatric surgical consultation.
SETTING: A multidisciplinary, private, bariatric center of excellence.
METHODS: Patient surveyed in person regarding preconsultation co-morbidities, physician discussion and support for bariatric surgery, and physician referral practices.
RESULTS: The patients' (n = 388) co-morbid profile was 27.0% diabetes, 54.1% hypertension, 30.1% hyperlipidemia, and 37.1% obstructive sleep apnea. It was reported that 71.1% of patients stated that their primary care physician did not initiate a discussion about bariatric surgery. Among this group, 59.7% of patients initiated a conversation about bariatric surgery, with 80.6% of physicians supporting the decision and 18.4% referring to a bariatric practice. Overall referring specialty profile was 14.4% primary care, 4.4% cardiology, and 3.6% endocrinology. Diabetes and obstructive sleep apnea were more likely to prompt a referral (P = .008 and P = .014, respectively).
CONCLUSION: Most primary care and subspecialists do not discuss bariatric surgical options, resulting in decreased access to bariatric care. The main barrier to referral is noncommunication by the primary care physician or subspecialist, despite the vast majority of physicians having positive attitudes about bariatric surgery. Co-morbidities of diabetes and obstructive sleep apnea are more likely to prompt a referral. Primary care physicians are most likely to refer, while endocrinologists are least likely. Improved familiarity with nationally recognized obesity management algorithms could contribute to improved referral rates.
Copyright © 2016 American Society for Bariatric Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords: 

Mesh:

Year:  2016        PMID: 28341364     DOI: 10.1016/j.soard.2016.08.016

Source DB:  PubMed          Journal:  Surg Obes Relat Dis        ISSN: 1550-7289            Impact factor:   4.734


  7 in total

Review 1.  Reasons for underutilization of bariatric surgery: The role of insurance benefit design.

Authors:  Hamlet Gasoyan; Gabriel Tajeu; Michael T Halpern; David B Sarwer
Journal:  Surg Obes Relat Dis       Date:  2018-10-13       Impact factor: 4.734

Review 2.  [Referral behavior of general physicians for patients with obesity].

Authors:  F U Jung; C Luck-Sikorski; C Stroh; S G Riedel-Heller
Journal:  Chirurg       Date:  2018-08       Impact factor: 0.955

Review 3.  Mindset and Communication Barriers in the Diffusion of Bariatric Surgery.

Authors:  Daniel Gero; Bors Hulesch; Marco Bueter
Journal:  Curr Atheroscler Rep       Date:  2018-05-21       Impact factor: 5.113

Review 4.  Integrated Care Model of Adiposity-Related Chronic Diseases.

Authors:  Thierry H Le Jemtel; Rohan Samson; Suzanne Oparil
Journal:  Curr Hypertens Rep       Date:  2022-09-09       Impact factor: 4.592

5.  Primary Care Physicians' Perceptions of Bariatric Surgery and Major Barriers to Referral.

Authors:  Eliza A Conaty; Woody Denham; Stephen P Haggerty; John G Linn; Raymond J Joehl; Michael B Ujiki
Journal:  Obes Surg       Date:  2020-02       Impact factor: 4.129

6.  Comment on: Socioecological factors associated with metabolic and bariatric surgery utilization: a qualitative study in an ethnically diverse sample.

Authors:  Numa P Perez; Fatima Cody Stanford; David C Chang
Journal:  Surg Obes Relat Dis       Date:  2020-03-13       Impact factor: 3.709

7.  Current Knowledge and Perceptions of Bariatric Surgery among Diabetologists and Internists in Poland.

Authors:  Karolina Zawadzka; Krzysztof Więckowski; Tomasz Stefura; Piotr Major; Magdalena Szopa
Journal:  J Clin Med       Date:  2022-04-05       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.